| Year | Q2 2024 | Q1 2024 |
|---|---|---|
| Total Revenue | 1.72B | 1.65B |
| Cost of Revenue | 541.7M | 930.4M |
| Gross Profit | 1.18B | 723.8M |
| Operating Expenses | 1.18B | 386M |
| Research and Development | 0 | 0 |
| Selling, General & Administrative Expenses | 0 | 386M |
| Selling & Marketing Expenses | 0 | 0 |
| General & Administrative Expenses | 0 | 0 |
| Other Expenses | 1.18B | 0 |
| Operating Income | 406.2M | 337.8M |
| Total Other Income/Expenses Net | -255.3M | 22.2M |
| Income Before Tax | 150.9M | 360M |
| Income Tax | 108.9M | 92.4M |
| Net Income | 42M | 267.6M |
| Basic EPS | 2.54 | 16.18 |
| EPS Diluted | 2.54 | 16.18 |
| Basic Average Shares | 16.54M | 16.54M |
| Diluted Average Shares | 16.54M | 16.54M |
| EBITDA | 205.7M | 414.4M |
RPG Life Sciences Limited
RPGLIFE.NS
NSE
1969.5INR-69.2 (-3.39%)
RPGLIFE.NS Financial Statements
Retained Earning Schedule
| Year |
|---|
| Retained Earnings (Previous Year) |
| Net Income |
| Stock Repurchases |
| Dividend Paid |
| Retained Earnings |
| Other Distributions |
PPE Schedule
| Year |
|---|
| Gross PPE |
| Annual Depreciation |
| Capital Expenditure |
| Net PPE |
Intangible and Goodwill Schedule
| Year |
|---|
| Acquisitions and Adjustments |
| Goodwill (Previous Year) |
| Goodwill |